Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88


Determinants of increased central excess pressure in dialysis: role of dialysis modality and arteriovenous fistula.

Paré M, Goupil R, Fortier C, Mac-Way F, Madore F, Marquis K, Hametner B, Wassertheurer S, Schultz MG, Sharman JE, Agharazii M.

Am J Hypertens. 2019 Aug 17. pii: hpz136. doi: 10.1093/ajh/hpz136. [Epub ahead of print]


Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy.

Pelletier K, Bonnefoy A, Chapdelaine H, Pichette V, Lejars M, Madore F, Brachemi S, Troyanov S.

Kidney Int Rep. 2019 Mar 20;4(6):797-805. doi: 10.1016/j.ekir.2019.03.004. eCollection 2019 Jun.


Fracture status in middle-aged individuals with early CKD: cross-sectional analysis of the CARTaGENE survey.

Desbiens LC, Goupil R, Sidibé A, Madore F, Mac-Way F.

Osteoporos Int. 2019 Apr;30(4):787-795. doi: 10.1007/s00198-019-04902-1. Epub 2019 Feb 22.


Uromodulin in a Pathway Between Decreased Renal Urate Excretion and Albuminuria.

Krajcoviechova A, Marois-Blanchet FC, Troyanov S, Harvey F, Dumas P, Tremblay J, Cifkova R, Awadalla P, Madore F, Hamet P.

Am J Hypertens. 2019 Mar 16;32(4):384-392. doi: 10.1093/ajh/hpy190.


An Adjustable Dalteparin Sodium Dose Regimen for the Prevention of Clotting in the Extracorporeal Circuit in Hemodialysis: A Clinical Trial of Safety and Efficacy (the PARROT Study).

Soroka S, Agharazii M, Donnelly S, Roy L, Muirhead N, Cournoyer S, MacKinnon M, Pannu N, Barrett B, Madore F, Tennankore K, Wilson JA, Hilton F, Sherman N, Wolter K, Orazem J, Feugère G.

Can J Kidney Health Dis. 2018 Nov 4;5:2054358118809104. doi: 10.1177/2054358118809104. eCollection 2018.


Central and Brachial Blood Pressures, Statins, and Low-Density Lipoprotein Cholesterol: A Mediation Analysis.

Lamarche F, Agharazii M, Nadeau-Fredette AC, Madore F, Goupil R.

Hypertension. 2018 Mar;71(3):415-421. doi: 10.1161/HYPERTENSIONAHA.117.10476. Epub 2018 Jan 2.


Uric acid association with pulsatile and steady components of central and peripheral blood pressures.

Lepeytre F, Lavoie PL, Troyanov S, Madore F, Agharazii M, Goupil R.

J Hypertens. 2018 Mar;36(3):495-501. doi: 10.1097/HJH.0000000000001573.


The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients.

Lepeytre F, Cardinal H, Fradette L, Verhave J, Dorais M, LeLorier J, Pichette V, Madore F.

Clin Kidney J. 2017 Jun;10(3):375-380. doi: 10.1093/ckj/sfw144. Epub 2017 Feb 18.


Formulas for Calculated Osmolarity and Osmolal Gap: A Study of Diagnostic Accuracy.

Lepeytre F, Ghannoum M, Ammann H, Madore F, Troyanov S, Goupil R, Bouchard J.

Am J Kidney Dis. 2017 Sep;70(3):347-356. doi: 10.1053/j.ajkd.2017.03.023. Epub 2017 May 31.


Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values.

Bernier-Jean A, Beaubien-Souligny W, Goupil R, Madore F, Paquette F, Troyanov S, Bouchard J.

BMC Nephrol. 2017 Apr 28;18(1):141. doi: 10.1186/s12882-017-0552-3.


Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia.

Paquette F, Goupil R, Madore F, Troyanov S, Bouchard J.

Clin Kidney J. 2016 Aug;9(4):540-2. doi: 10.1093/ckj/sfw036. Epub 2016 May 26.


Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis.

Goupil R, Dupuis D, Troyanov S, Madore F, Agharazii M.

J Hypertens. 2016 Aug;34(8):1535-43. doi: 10.1097/HJH.0000000000000978.


Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE.

Goupil R, Dupuis D, Agharazii M, Hamet P, Troyanov S, Madore F.

Nephrol Dial Transplant. 2017 Jun 1;32(6):976-983. doi: 10.1093/ndt/gfw059.


Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.

Kim RB, Morse BL, Djurdjev O, Tang M, Muirhead N, Barrett B, Holmes DT, Madore F, Clase CM, Rigatto C, Levin A; CanPREDDICT Investigators.

Kidney Int. 2016 May;89(5):1144-1152. doi: 10.1016/j.kint.2016.01.014. Epub 2016 Mar 19.


Perceptions of prognostic risks in chronic kidney disease: a national survey.

Chiu HH, Tangri N, Djurdjev O, Barrett BJ, Hemmelgarn BR, Madore F, Rigatto C, Muirhead N, Sood MM, Clase CM, Levin A.

Can J Kidney Health Dis. 2015 Dec 20;2:53. doi: 10.1186/s40697-015-0088-z. eCollection 2015.


Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

Troyanov S, Delmas-Frenette C, Bollée G, Youhanna S, Bruat V, Awadalla P, Devuyst O, Madore F.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):62-9. doi: 10.2215/CJN.04770415. Epub 2015 Dec 18.


Establishing a Canadian national clinical trials network for kidney disease: proceedings of a planning workshop.

Rigatto C, Walsh M, Zalunardo N, Clase CM, Manns BJ, Madore F, Samuel SM, Morgan CJ, Wolfs W, Suri RS.

Can J Kidney Health Dis. 2015 Nov 17;2:46. doi: 10.1186/s40697-015-0080-7. eCollection 2015.


Plasmapheresis in cast nephropathy: yes or no?

Madore F.

Curr Opin Nephrol Hypertens. 2015 Mar;24(2):177-82. doi: 10.1097/MNH.0000000000000101. Review.


Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.

Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, Grill A, Karsanji M, Komenda P, Madore F, Manns BJ, Mahdavi S, Mustafa RA, Smyth A, Welcher ES.

Am J Kidney Dis. 2015 Feb;65(2):177-205. doi: 10.1053/j.ajkd.2014.10.013. Epub 2014 Nov 4. Review.


Carbamazepine poisoning treated by multiple extracorporeal treatments.

Payette A, Ghannoum M, Madore F, Albert M, Troyanov S, Bouchard J.

Clin Nephrol. 2015 Mar;83(3):184-8. doi: 10.5414/CN108290.


Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.

O'Meara E, Rouleau JL, White M, Roy K, Blondeau L, Ducharme A, Neagoe PE, Sirois MG, Lavoie J, Racine N, Liszkowski M, Madore F, Tardif JC, de Denus S; ANCHOR Investigators.

Circ Heart Fail. 2014 Sep;7(5):773-81. doi: 10.1161/CIRCHEARTFAILURE.114.001100. Epub 2014 Jul 15.


Longitudinal trends in sFas, a biomarker of apoptosis, after an acute coronary syndrome: clues to the pathogenesis underlying adverse events on follow-up.

Cardinal H, Madore F, Brophy JM, Joseph L, Hébert MJ, Min S, Boyer L, Bogaty P.

Int J Cardiol. 2014 May 15;173(3):603-7. doi: 10.1016/j.ijcard.2014.03.139. Epub 2014 Mar 22. No abstract available.


Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.

Verhave JC, Troyanov S, Mongeau F, Fradette L, Bouchard J, Awadalla P, Madore F.

Clin J Am Soc Nephrol. 2014 Apr;9(4):713-9. doi: 10.2215/CJN.06550613. Epub 2014 Jan 23.


The risk of thromboembolic events in kidney transplant patients.

Verhave JC, Tagalakis V, Suissa S, Madore F, Hébert MJ, Cardinal H.

Kidney Int. 2014 Jun;85(6):1454-60. doi: 10.1038/ki.2013.536. Epub 2014 Jan 15.


Establishing a national knowledge translation and generation network in kidney disease: the CAnadian KidNey KNowledge TraNslation and GEneration NeTwork.

Manns B, Barrett B, Evans M, Garg A, Hemmelgarn B, Kappel J, Klarenbach S, Madore F, Parfrey P, Samuel S, Soroka S, Suri R, Tonelli M, Wald R, Walsh M, Zappitelli M; CAnadian KidNey KNowledge TraNslation and GEneration NeTwork.

Can J Kidney Health Dis. 2014 Apr 7;1:2. doi: 10.1186/2054-3581-1-2. eCollection 2014. Review.


Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort.

Levin A, Rigatto C, Barrett B, Madore F, Muirhead N, Holmes D, Clase CM, Tang M, Djurdjev O; CanPREDDICT Investigators.

Nephrol Dial Transplant. 2014 May;29(5):1037-47. doi: 10.1093/ndt/gft479. Epub 2013 Dec 26.


Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study.

Verhave JC, Bouchard J, Goupil R, Pichette V, Brachemi S, Madore F, Troyanov S.

Diabetes Res Clin Pract. 2013 Sep;101(3):333-40. doi: 10.1016/j.diabres.2013.07.006. Epub 2013 Jul 20.


Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).

Levin A, Rigatto C, Brendan B, Madore F, Muirhead N, Holmes D, Clase CM, Tang M, Djurdjev O; CanPREDDICT investigators.

BMC Nephrol. 2013 Jun 11;14:121. doi: 10.1186/1471-2369-14-121.


Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends.

Lafrance JP, Cardinal H, Leblanc M, Madore F, Pichette V, Roy L, Le Lorier J.

BMC Nephrol. 2013 May 3;14:100. doi: 10.1186/1471-2369-14-100.


Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury.

Cardinal H, Dieudé M, Brassard N, Qi S, Patey N, Soulez M, Beillevaire D, Echeverry F, Daniel C, Durocher Y, Madore F, Hébert MJ.

Am J Transplant. 2013 Apr;13(4):861-874. doi: 10.1111/ajt.12168. Epub 2013 Feb 22.


Gene polymorphisms as clinical tools in chronic glomerulopathies: a prospective study.

Chapdelaine I, Goupil R, Azcoitia V, Rioux JP, Raymond-Carrier S, Madore F, Troyanov S.

Nephron Clin Pract. 2012;121(3-4):c174-9. doi: 10.1159/000346404. Epub 2013 Jan 23. Review.


Plasmapheresis in myeloma cast nephropathy.

Chapdelaine I, Madore F.

Clin Nephrol. 2013 Jan;79(1):72-7.


The sonographic digital portfolio: a longitudinal ultrasound image tracking program.

Hughes DR, Kube E, Gable BD, Madore FE, Bahner DP.

Crit Ultrasound J. 2012 Jul 2;4(1):15. doi: 10.1186/2036-7902-4-15.


Alteration of the platelet transcriptome in chronic kidney disease.

Plé H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P.

Thromb Haemost. 2012 Oct;108(4):605-15. Epub 2012 Jul 26.


The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection.

Soulez M, Pilon EA, Dieudé M, Cardinal H, Brassard N, Qi S, Wu SJ, Durocher Y, Madore F, Perreault C, Hébert MJ.

Circ Res. 2012 Jan 6;110(1):94-104. doi: 10.1161/CIRCRESAHA.111.250431. Epub 2011 Nov 10.


Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.

Camilla R, Brachemi S, Pichette V, Cartier P, Laforest-Renald A, MacRae T, Madore F, Troyanov S.

J Nephrol. 2011 Jan-Feb;24(1):60-7.


[Are cardioprotective drugs underused after a myocardial infarction in patients who suffer from chronic kidney disease?].

Cardinal H, Madore F.

Nephrol Ther. 2010 Jun;6(3):162-70. doi: 10.1016/j.nephro.2009.10.003. Epub 2010 Mar 25. Review. French.


Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes.

Cardinal H, Brophy JM, Bogaty P, Joseph L, Hébert MJ, Boyer L, Madore F.

Am J Cardiol. 2010 Mar 15;105(6):797-803. doi: 10.1016/j.amjcard.2009.10.061.


Therapeutic management in patients with renal failure who experience an acute coronary syndrome.

Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy JM.

Clin J Am Soc Nephrol. 2010 Jan;5(1):87-94. doi: 10.2215/CJN.04290609. Epub 2009 Oct 29.


Periodontal disease: a modifiable risk factor for cardiovascular disease in ESRD patients?

Madore F.

Kidney Int. 2009 Apr;75(7):672-4. doi: 10.1038/ki.2009.15. Review.


Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery.

Rioux JP, Lessard M, De Bortoli B, Roy P, Albert M, Verdant C, Madore F, Troyanov S.

Crit Care Med. 2009 Apr;37(4):1293-8. doi: 10.1097/CCM.0b013e31819cc1a0.


Guidelines for the management of chronic kidney disease.

Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M; Canadian Society of Nephrology.

CMAJ. 2008 Nov 18;179(11):1154-62. doi: 10.1503/cmaj.080351. Review. No abstract available.


Clinical practice guidelines for assessment and management of iron deficiency.

Madore F, White CT, Foley RN, Barrett BJ, Moist LM, Klarenbach SW, Culleton BF, Tonelli M, Manns BJ; Canadian Society of Nephrology.

Kidney Int Suppl. 2008 Aug;(110):S7-S11. doi: 10.1038/ki.2008.269. No abstract available.


Clinical practice guidelines for evaluation of anemia.

White CT, Barrett BJ, Madore F, Moist LM, Klarenbach SW, Foley RN, Culleton BF, Tonelli M, Manns BJ; Canadian Society of Nephrology.

Kidney Int Suppl. 2008 Aug;(110):S4-6. doi: 10.1038/ki.2008.268. No abstract available.


Clinical practice guidelines for supplemental therapies and issues.

Klarenbach SW, Moist LM, Foley RN, Barrett BJ, Madore F, White CT, Culleton BF, Tonelli M, Manns BJ; Canadian Society of Nephrology.

Kidney Int Suppl. 2008 Aug;(110):S19-24. doi: 10.1038/ki.2008.271. No abstract available.


Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.

Moist LM, Foley RN, Barrett BJ, Madore F, White CT, Klarenbach SW, Culleton BF, Tonelli M, Manns BJ; Canadian Society of Nephrology.

Kidney Int Suppl. 2008 Aug;(110):S12-8. doi: 10.1038/ki.2008.270. No abstract available.


Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease.

Manns BJ, White CT, Madore F, Moist LM, Klarenbach SW, Barrett BJ, Foley RN, Culleton BF, Tonelli M.

Kidney Int Suppl. 2008 Aug;(110):S1-3. doi: 10.1038/ki.2008.267. No abstract available.


[Candidemia and granulomatous tubulointerstitial nephritis].

Benoit G, Mandalenakis N, Faucher C, Madore F.

Nephrol Ther. 2008 Jul;4(4):278-9. doi: 10.1016/j.nephro.2008.03.008. Epub 2008 Jun 3. French.


Supplemental Content

Loading ...
Support Center